Back to Search Start Over

Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016

Authors :
Stovner, Lars Jacob
Nichols, Emma
Steiner, Timothy J.
Abd-Allah, Foad
Abdelalim, Ahmed
Al-Raddadi, Rajaa M.
Ansha, Mustafa Geleto
Barac, Aleksandra
Bensenor, Isabela M.
Doan, Linh Phuong
Edessa, Dumessa
Endres, Matthias
Foreman, Kyle J.
Gankpe, Fortune Gbetoho
Gopalkrishna, Gururaj
Goulart, Alessandra C.
Gupta, Rahul
Hankey, Graeme J.
Hay, Simon I.
Hegazy, Mohamed I.
Hilawe, Esayas Haregot
Kasaeian, Amir
Kassa, Dessalegn H.
Khalil, Ibrahim
Khang, Young-Ho
Khubchandani, Jagdish
Kim, Yun Jin
Kokubo, Yoshihiro
Mohammed, Mohammed A.
Moradi-Lakeh, Maziar
Nguyen, Huong Lan Thi
Nirayo, Yirga Legesse
Qorbani, Mostafa
Ranta, Anna
Roba, Kedir T.
Safiri, Saeid
Santos, Itamar S.
Satpathy, Maheswar
Sawhney, Monika
Shiferaw, Mekonnen Sisay
Shiue, Ivy
Smith, Mari
Szoeke, Cassandra E.I.
Truong, Nu Thi
Venketasubramanian, Narayanaswamy
Weldegwergs, Kidu Gidey
Westerman, Ronny
Wijeratne, Tissa
Tran, Bach Xuan
Yonemoto, Naohiro
Feigin, Valery L.
Vos, Theo
Murray, Christopher J.L.
Source :
Lancet Neurology
Publication Year :
2018
Publisher :
Elsevier Inc., 2018.

Abstract

Background Through the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability (YLDs) for migraine and tension-type headache and to present the methods and results in an accessible way for clinicians and researchers of headache disorders. Methods Data were derived from population-based cross-sectional surveys on migraine and tension-type headache. Prevalence for each sex and 5-year age group interval (ie, age 5 years to ≥95 years) at different time points from 1990 and 2016 in all countries and GBD regions were estimated using a Bayesian meta-regression model. Disease burden measured in YLDs was calculated from prevalence and average time spent with headache multiplied by disability weights (a measure of the relative severity of the disabling consequence of a disease). The burden stemming from medication overuse headache, which was included in earlier iterations of GBD as a separate cause, was subsumed as a sequela of either migraine or tension-type headache. Because no deaths were assigned to headaches as the underlying cause, YLDs equate to disability-adjusted life-years (DALYs). We also analysed results on the basis of the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility. Findings Almost three billion individuals were estimated to have a migraine or tension-type headache in 2016: 1·89 billion (95% uncertainty interval [UI] 1·71–2·10) with tension-type headache and 1·04 billion (95% UI 1·00–1·09) with migraine. However, because migraine had a much higher disability weight than tension-type headache, migraine caused 45·1 million (95% UI 29·0–62·8) and tension-type headache only 7·2 million (95% UI 4·6–10·5) YLDs globally in 2016. The headaches were most burdensome in women between ages 15 and 49 years, with migraine causing 20·3 million (95% UI 12·9–28·5) and tension-type headache 2·9 million (95% UI 1·8–4·2) YLDs in 2016, which was 11·2% of all YLDs in this age group and sex. Age-standardised DALYs for each headache type showed a small increase as SDI increased. Interpretation Although current estimates are based on limited data, our study shows that headache disorders, and migraine in particular, are important causes of disability worldwide, and deserve greater attention in health policy debates and research resource allocation. Future iterations of this study, based on sources from additional countries and with less methodological heterogeneity, should help to provide stronger evidence of the need for action. © 2018 The Author(s). Published by Elsevier Ltd.This article is available under the terms of the Creative Commons Attribution License (CC BY). You may copy and distribute the article, create extracts, abstracts and new works from the article, alter and revise the article, text or data mine the article and otherwise reuse the article commercially (including reuse and/or resale of the article) without permission from Elsevier. You must give appropriate credit to the original work, together with a link to the formal publication through the relevant DOI and a link to the Creative Commons user license above. You must indicate if any changes are made but not in any way that suggests the licensor endorses you or your use of the work.

Details

Language :
English
Database :
OpenAIRE
Journal :
Lancet Neurology
Accession number :
edsair.dedup.wf.001..b1fde68e8d561c2f3b0a8704b782814c